The Vertical Group — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.
BiotechHardwareHealthtechMedical DevicesSan Mateo, US
Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)Tony Chou(Executive Officer, Director)in
BoardJack Lasersohn(Director)inTamir Meiri(Director)Jonathan Root(Director)in
Board seatJack W. Lasersohn· per SEC Form D · $50M raise · filed Apr 2026
Co-investorsNorwest Venture PartnersRunway Growth CapitalUS Venture PartnersSofinnova Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.